Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06040697 · ClinicalTrials.gov registry record

Formative Usability Assessment of Wireless Thermal Anisotropy Devices

A clinical trial of Hydrocephalus, sponsored by Rhaeos.

Recruiting
Registry status
145
Enrollment target
1
Study location

NCT06040697 is a study of Hydrocephalus that is actively recruiting participants, run by Rhaeos. The registered enrollment target is 145 participants, above the 125-participant average among 17 other Hydrocephalus trials with a reported enrollment target (16% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06040697, a study of Hydrocephalus, is actively recruiting participants, sponsored by Rhaeos.

RECRUITING
Registry status
145 participants
Enrollment target
1
Study location

Study Summary

Measurements of shunt flow will be performed non-invasively. This study will generate usability data via observed tasks and comprehension questions to enable future device design improvements.

Conditions Studied

Hydrocephalus

Interventions

  • DEVICE Thermal Anisotropy

Study Locations (1)

Illinois

  • Rhaeos, Inc. - Chicago

Trial Details

FieldValue
Enrollment Target 145 participants
Start Date 2023-09-29
Est. Completion 2025-12

Sponsor

Rhaeos

15 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06040697

The ClinicalTrials.gov registry entry for NCT06040697 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 125-participant average among 17 other Hydrocephalus trials with a reported enrollment target (16% higher). The listed sponsor is Rhaeos, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hydrocephalus appearing as the primary indexed condition, and to 1 intervention - of which Thermal Anisotropy is the first listed.

NCT06040697 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06040697 about?

NCT06040697 is a clinical study titled "Formative Usability Assessment of Wireless Thermal Anisotropy Devices". Measurements of shunt flow will be performed non-invasively. This study will generate usability data via observed tasks and comprehension questions to enable future device design improvements.

What is the current status of trial NCT06040697?

This trial is currently recruiting. The enrollment target is 145 participants. The study started on 2023-09-29. Estimated completion is 2025-12.

What conditions does trial NCT06040697 study?

This clinical trial studies the following conditions: Hydrocephalus.

What interventions are being tested in trial NCT06040697?

The interventions under investigation include: Thermal Anisotropy (DEVICE).

Who is sponsoring clinical trial NCT06040697?

This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06040697 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hydrocephalus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hydrocephalus

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.